Lymphocyte DNA damage is associated with increased aortic intima-media thickness

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 617, Issue 1-2, 2007, Pages 111-118

  Gur, Mustafa ^a   Yilmaz, Remzi ^a   Demirbag, Recep ^a   Yildiz, Ali ^a   Kocyigit, Abdurrahim ^a   Celik, Hakim ^a   Cayli, Murat ^b   Polat, Mustafa ^a   Bas, M Menduh ^a  

^a HARRAN UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Antioxidant status; Aorta; Atherosclerosis; DNA damage; Intima media thickness

Indexed keywords

CELL DNA; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTIOXIDANT ACTIVITY; AORTA ATHEROSCLEROSIS; AORTA INTIMA; AORTA MEDIA; ARTERY INTIMA PROLIFERATION; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMET ASSAY; DISEASE ASSOCIATION; DISEASE COURSE; DNA DAMAGE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; ANTIOXIDANTS; AORTA; CAROTID ARTERIES; COMET ASSAY; DNA DAMAGE; FEMALE; HUMANS; LYMPHOCYTES; MALE; TUNICA INTIMA; TUNICA MEDIA;

EID: 33847693560     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.01.011     Document Type: Article

References (41)

1. Mahmoudi M., Mercer J., and Bennett M. DNA damage and repair in atherosclerosis. Cardiovasc. Res. 71 (2006) 259-268 (review)
2. Andreassi M.G., and Botto N. DNA damage as a new emerging risk factor in atherosclerosis. Trends Cardiovasc. Med. 13 (2003) 270-275 (review)
3. De Flora S., Izzotti A., Walsh D., Degan P., Petrilli G.L., and Lewtas J. Molecular epidemiology of atherosclerosis. FASEB J. 11 (1997) 1021-1031
4. Binkova B., Smerhovsky Z., Strejc P., Boubelik O., Stavkova Z., Chvatalova I., and Sram R.J. DNA-adducts and atherosclerosis: a study of accidental and sudden death males in the Czech Republic. Mutat. Res. 501 (2002) 15-28
5. Martinet W., Knaapen M.W., De Meyer G.R., Herman A.G., and Kockx M.M. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106 (2002) 927-932
6. Botto N., Rizza A., Colombo M.G., Mazzone A.M., Manfredi S., Masetti S., Clerico A., Biagini A., and Andreassi M.G. Evidence for DNA damage in patients with coronary artery disease. Mutat. Res. 493 (2001) 23-30
7. Botto N., Masetti S., Petrozzi L., Vassalle C., Manfredi S., Biagini A., and Andreassi M.G. Elevated levels of oxidative DNA damage in patients with coronary artery disease. Coron. Artery Dis. 13 (2002) 269-274
8. Demirbag R., Yilmaz R., Gur M., Kocyigit A., Celik A., Guzel S., and Selek S. Lymphocyte DNA damage in patients with acute coronary syndrome and its relationship with severity of acute coronary syndrome. Mutat Res. 578 (2005) 298-307
9. Demirbag R., Yilmaz R., and Kocyigit A. Relationship between DNA damage, total antioxidant capacity and coronary artery disease. Mutat. Res. 570 (2005) 197-203
10. Andreassi M.G. Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage. Mutat. Res. 543 (2003) 67-86
11. Lee J., Lee M., Kim J.K., Song K., Choi Y.S., and Cheong S.S. Carvedilol reduces plasma 8-hydroxy-2-deoxyguanosine in mild to moderate hypertension a pilot study. Hypertension 45 (2005) 986-990
12. Khatibzadeh M., Mitusch R., Stierle U., Gromoll B., and Sheikhzadeh A. Aortic atherosclerotic plaques as a source of systemic embolism. J Am Coll Cardiol 27 (1996) 664-669
13. Acarturk E., Demir M., and Kanadasi M. Aortic atherosclerosis is a marker for significant coronary artery disease. Jpn. Heart J. 40 (1999) 775-781
14. Witteman J.C., Kannel W.B., Wolf P.A., Grobbee D.E., Hofman A., D'Agostino R.B., and Cobb J.C. Aortic calcified plaques and cardiovascular disease (the Framingham Study). Am. J. Cardiol. 66 (1990) 1060-1064
15. Nihoyannopoulos P., Joshi J., Athanasopoulos G., and Oakley C.M. Detection of atherosclerotic lesions in the aorta by transesophageal echocardiography. Am. J. Cardiol 71 (1993) 1208-1212
16. Ames B.N. Endogenous DNA damage as related to cancer and ageing. Free Radic. Res. Commun. 7 (1989) 121-128
17. Buczynski A., Wachowicz B., Kedziora-Kornatowska K., Tkaczewski W., and Kedziora J. Changes in antioxidant enzymes activities, aggregability and malonyldialdehyde concentration in blood platelets from patients with coronary heart disease. Atherosclerosis 100 (1993) 223-228
18. Ceriello A., Giugliano D., Quatraro A., and Lefebvre P.J. Anti-oxidants show antihypertensive effect in diabetic and hypertensive subjects. Clin. Sci. 81 (1991) 739-742
19. Galley H.F., Thornton J., Howdle P.D., Walker B.E., and Webster N.R. Combination oral antioxidant supplementation reduce blood pressure. Clin. Sci. 92 (1997) 361-365
20. Russo C., Olivieri O., Girelli D., Faccini G., Zenari M.L., Lombardi S., and Corrocher R. Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J. Hypertens. 16 (1998) 1267-1271
21. Halliwell B., and Aruoma O. DNA damage by oxygen-derived species: its mechanism and measurement in mammalian systems. FEBS Lett. 281 (1991) 9-19
22. Demirbag R., Yilmaz R., Kunt A.S., Gur M., Ulucay A., and Unlu D. Relationship between plasma total antioxidant capacity and thoracic aortic intima-media thickness. Echocardiography 23 (2006) 183-188
23. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
24. Teichholz L.E., Kreulen T., Herman M.V., and Gorlin R. Problems in echocardiographic volume determinations: echocardiographic- angiographic correlations in the presence of absence of asynergy. Am. J. Cardiol. 37 (1976) 7-11
25. Rohani M., Jogestrand T., Ekberg M., van der Linden J., Kallner G., Jussila R., and Agewall S. Interrelation between the extent of atherosclerosis in the thoracic aorta, carotid intima-media thickness and the extent of coronary artery disease. Atherosclerosis 179 (2005) 311-316
26. Singh P.N., McCoy M.T., Tice R.R., and Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175 (1988) 184-191
27. Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin. Biochem. 37 (2004) 112-119
28. Halliwell B. Free radicals, antioxidants and human disease: curiosity, cause, or consequences?. Lancet 344 (1994) 721-724
29. Chen L.Y., Nichols W.W., Hendricks J., and Mehta J.L. Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis. Am Heart J. 129 (1995) 211-218
30. Rice Evans C., and Miller N.J. Total antioxidant status in plasma and body fluids. Meth. Enzymol. 234 (1994) 279-293
31. Honda M., Yamada Y., Tomonaga M., Ichinose H., and Kamihira S. Correlation of urinary 8-hydroxy-2-de-oxyguanosine (8-OHdG), a biomarker of oxidative DNA dam-age, and clinical features of hematological disorders: a pilot study. Leuk. Res. 24 (2000) 461-468
32. Stringer M.D., Görög P.G., Freeman A., and Kakkar V.V. Lipid peroxides and atherosclerosis. Br. Med. J. 298 (1989) 281-284
33. Kovacs I.B., Jahangiri M., Rees G.M., and Görög P. Elevated plasma lipid hydroperoxides in patients with coronary artery disease. Am. Heart J. 134 (1997) 572-576
34. Andreassi M.G., Botto N., Cocci F., Battaglia D., Antonioli E., Masetti S., Manfredi S., Colombo M.G., Biagini A., and Clerico A. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Hum. Genet. 112 (2003) 171-177
35. Botto N., Berti S., Manfredi S., Al-Jabri A., Federici C., Clerico A., Ciofini E., Biagini A., and Andreassi M.G. Detection of mtDNA with 4977bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery disease. Mutat Res. 570 (2005) 81-88
36. Lee J.W., Harrigan J., Opresko P.L., and Bohr V.A. Pathways and functions of the Werner syndrome protein. Mech. Ageing Dev. 126 (2005) 79-86
37. Casalone R., Granata P., Minelli E., Portentoso P., Giudici A., Righi R., Castelli P., Socrate A., Frigerio B., Casalone R., Granata P., Minelli E., Portentoso P., Giudici A., Righi R., et al. Cytogenetic analysis reveals clonal proliferation of smooth muscle cells in atherosclerotic plaques. Hum. Genet. 87 (1991) 139-143
38. Matturri L., Cazzullo A., Turconi P., Lavezzi A.M., Vandone P.L., Gabrielli L., Fernandez Alonso G., Grana D., and Milei J. Chromosomal alterations in atherosclerotic plaques. Atherosclerosis 15 (2001) 755-761
39. Ballinger S.W., Patterson C., Knight-Lozano C.A., Burow D.L., Conklin C.A., Hu Z., Reuf J., Horaist C., Lebovitz R., Hunter G.C., McIntyre K., and Runge M.S. Mitochondrial integrity and function in atherogenesis. Circulation 106 (2002) 544-549
40. Nishino M., Masugata H., Yamada Y., Abe H., Hori M., and Kamada T. Evaluation of thoracic aortic atherosclerosis by transesophageal echocardiography. Am. Heart J. 127 (1994) 336-344
41. Matsuzaki M., Ono S., Tomochika Y., Michishige H., Tanaka N., Okuda F., and Kusukawa R. Advances in transesophageal echocardiography for the evaluation of atherosclerotic lesions in thoracic aorta-the effects of hypertension, hypercholesterolemia, and aging on atherosclerotic lesions. Jpn. Circ. J. 56 (1992) 592-602